Search Results - Josh Poorbaugh

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions. by Josh Poorbaugh, Jonathan T Sims, Lin Zhang, Ching-Yun Chang, Richard E Higgs, Ajay Nirula, Robert J Benschop

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  2. 2

    Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoc... by Jonathan T. Sims, Josh Poorbaugh, Ching-Yun Chang, Timothy R. Holzer, Lin Zhang, Sarah M. Engle, Stephanie Beasley, Thompson N. Doman, Lynn Naughton, Richard E. Higgs, Nicole Kallewaard, Robert J. Benschop

    Published in Journal of Translational Medicine (2022-03-01)
    Get full text
    Article


  3. 3

    Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients by Jonathan T. Sims, Ching-Yun Chang, Josh Poorbaugh, Montanea Daniels, Stephanie L. Beasley, Lin Zhang, George H. Rodgers, Fabio Lena, Leonardo G. Lacerenza, Bruno Sposato, Annabelle Dupont, Sophie Susen, Giacomo Casalini, Mario Corbellino, Justin Stebbing, Venkatesh Krishnan

    Published in Journal of Translational Medicine (2022-09-01)
    Get full text
    Article


  4. 4

    Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression by Anna-Mari Schroderus, Josh Poorbaugh, Samantha McElyea, Stephanie Beasley, Lin Zhang, Kirsti Näntö-Salonen, Reeta Rintamäki, Jussi Pihlajamäki, Jussi Pihlajamäki, Mikael Knip, Mikael Knip, Mikael Knip, Riitta Veijola, Jorma Toppari, Jorma Toppari, Jorma Ilonen, Robert J. Benschop, Tuure Kinnunen, Tuure Kinnunen

    Published in Frontiers in Immunology (2023-06-01)
    Get full text
    Article


  5. 5

    Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study by Anja Koester, Derrick R. Witcher, Mark Lee, Stephen J. Demarest, Scott Potter, Katie Werle, Scott Bauer, Diana Ruiz, Laurent Malherbe, Josh Poorbaugh, Andrew Glasebrook, Christoph Preuss, Gourab Datta, Ziqiao Wang, Jack Knorr, David Manner, Dipak Patel, Carsten Schmitz, Paul Klekotka, Ajay Nirula

    Published in Nature Communications (2025-05-01)
    Get full text
    Article


  6. 6

    Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together by Lin Zhang, Josh Poorbaugh, Michael Dougan, Peter Chen, Robert L. Gottlieb, Robert L. Gottlieb, Gregory Huhn, Stephanie Beasley, Montanea Daniels, Thi Ngoc Vy Trinh, Melissa Crisp, Joshua Joaquin Freitas, Peter Vaillancourt, Dipak R. Patel, Ajay Nirula, Nicole L. Kallewaard, Richard E. Higgs, Robert J. Benschop

    Published in Frontiers in Immunology (2021-12-01)
    Get full text
    Article


Search Tools: